Abstract
Aims and objectives: To explore dosing patterns and self-injection barriers in administrating erythropoiesis-stimulating agent (ESA) treatment in patients with chronic kidney disease, not on dialysis (CKD-ND). Method: In a multicenter, cross-sectional study in Sweden, 385 CKD-ND patients were assessed for ESA administration patterns and barriers to self-injection. Results: 121 participants (31%) did not self-inject ESA. Of the assisted patients, 88 (73%) had ESA administered by district nurses and 33 (27%) by relatives. Assistance was more common among patients ≥65 years. Injection fear, uncertainty, convenience and physical handicaps were common barriers to self-injection. Conclusions: A range of barriers may influence the patients’ ability to self-inject ESA. These should be addressed and further elucidated. Renal nurses as well as other caregivers need to explore the patients’ perspective, address injection related anxiety, handling difficulties and support and educate CKD-ND patients to enhance their self-care agency regarding anaemia management.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
